Evercore ISI keeps Outperform on seven stocks but cuts all their price targets
Evercore ISI kept Outperform ratings on Carrier, Intel, Illumina, Hershey, SanDisk, SkyWest and NovoCure, lowering price targets on all seven, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, citing Benzinga data, Evercore ISI Group reiterated its Outperform rating on seven companies on October 30, 2026, and reduced the price target on each. Carrier Global's target fell to $75 from $90, Intel's to $131 from $133, Illumina's to $275 from $290, Hershey's to $200 from $210, SanDisk's to $2500 from $2800, SkyWest's to $125 from $130 and NovoCure's to $20 from $23.
The source notes that Illumina's new target implies a 5.2% downside from its October 29 close of $290.06, while the targets for the other six stocks sit above their October 29 closing prices.
why it matters
Target cuts of this kind are routine and usually move individual shares rather than the broader market. Investors often compare them with each bank's rating history and with recent calls from other brokers on the same stocks.
tags
instruments
sources
- Evercore ISI Group maintains Carrier Global at Outperform, lowers price target to $75 from $90 — TradingView, 30 October 2026 at 12:22 UTC
- Evercore ISI Group maintains Intel at Outperform, lowers price target to $131 from $133 — TradingView, 30 October 2026 at 12:36 UTC
- Evercore ISI Group maintains Illumina at Outperform, lowers price target to $275 from $290 — TradingView, 30 October 2026 at 12:35 UTC
- Evercore ISI Group maintains Hershey at Outperform, lowers price target to $200 from $210 — TradingView, 30 October 2026 at 12:34 UTC
- Evercore ISI Group maintains SanDisk at Outperform, lowers price target to $2500 from $2800 — TradingView, 30 October 2026 at 12:45 UTC
- Evercore ISI Group maintains SkyWest at Outperform, lowers price target to $125 from $130 — TradingView, 30 October 2026 at 12:44 UTC
- Evercore ISI Group maintains NovoCure at Outperform, lowers price target to $20 from $23 — TradingView, 30 October 2026 at 12:40 UTC
- Evercore ISI Group maintains Willis Towers Watson at Outperform, lowers price target to $371 from $374 — TradingView, 30 October 2026 at 12:47 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗